-
News: Lynparza may be able to treat more breast cancers
Lynparza is a PARP inhibitor used to treat breast cancer in people with an inherited BRCA mutation. A small study found that Lynparza could also treat metastatic breast cancer in people with an inherited PALB2 mutation or who have breast cancer that has developed a BRCA mutation over time. This means that many more people…
-
Genetic Mutations More Likely in Breast Cancer Found Between Mammograms
Genetic Mutations More Likely in Breast Cancer Found Between Mammograms May 15, 2024 Having a family history of breast cancer and a mutation in any of the five main breast cancer genes may increase the chance that you may discover breast cancer between your routine mammograms. Read more…
-
PALB2
I’m only 33 and I tested positive for 4 different mutations. One of them was PALB2. My mother and her mother both had and past away from breast cancer. I fell like my dr. Isn’t very concerned about it being positive, but I am. what are some steps other then annual mammograms that I can take to prevent the cancer from…